Boxer Capital LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:02 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 0 0.000% |
-3,163,795 (Position Closed) |
Filing |
| 2023-02-14 1:10 pm Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 3,163,795 6.900% |
325,559 (+11.47%) |
Filing |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,838,236 6.300% |
570,000 (+25.13%) |
Filing |
| 2020-09-30 4:33 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,268,236 5.100% |
2,268,236 (New Position) |
Filing |